Cargando...
Inhibition of P-Glycoprotein Does Not Increase the Efficacy of Proteasome Inhibitors in Multiple Myeloma Cells
[Image: see text] P-Glycoprotein is a well-known drug transporter associated with chemotherapy resistance in a number of cancers, but its role in modulating proteasome inhibitor efficacy in multiple myeloma is not well understood. The second-generation proteasome inhibitor carfilzomib is thought to...
Gardado en:
| Publicado en: | ACS Pharmacol Transl Sci |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American
Chemical Society
2021
|
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8033612/ https://ncbi.nlm.nih.gov/pubmed/33860196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.0c00200 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|